Crossmark

Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

Crossref DOI link: https://doi.org/10.1038/s41436-018-0068-7

Published Print: 2018-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Calsina, Bruna

Currás-Freixes, Maria

Buffet, Alexandre

Pons, Tirso

Contreras, Laura

Letón, Rocío

Comino-Méndez, Iñaki

Remacha, Laura

Calatayud, María

Obispo, Berta

Martin, Antoine

Cohen, Regis

Richter, Susan

Balmaña, Judith

Korpershoek, Esther

Rapizzi, Elena

Deutschbein, Timo

Vroonen, Laurent

Favier, Judith

de Krijger, Ronald R.

Fassnacht, Martin

Beuschlein, Felix

Timmers, Henri J.

Eisenhofer, Graeme

Mannelli, Massimo

Pacak, Karel

Satrústegui, Jorgina

Rodríguez-Antona, Cristina

Amar, Laurence

Cascón, Alberto

Dölker, Nicole

Gimenez-Roqueplo, Anne-Paule

Robledo, Mercedes
License Information

Text and Data Mining valid from 2018-12-01

Text and Data Mining valid from 2018-12-01

Version of Record valid from 2022-01-19
More Information

This article is maintained by: Elsevier

Article Title: Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41436-018-0068-7

Content Type: article

Copyright: © 2018, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics